{"database": "lobbying", "table": "lobbying_activities", "rows": [[1510966, "1e0d3630-2089-492f-a02b-e9c8fae234d5", "Q1", "BLANK ROME GOVERNMENT RELATIONS", 6325, "EMERGENT BIOSOLUTIONS INC.", 2014, "first_quarter", "DEF", "Issues relating to Reactive Skin Decontamination Lotion (RSDL), including relevant provisions in the National Defense Authorization Act (H.R. 1960) and in FY 2014 Appropriations Bills", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2014-02-07T16:24:52.380000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1510966"], "units": {}, "query_ms": 82.37703901249915, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}